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Sir, We thank Dr Bramsen for her interest in our recently publi-
shed article (de Lange et al. 2008). In this article, we report on
an increase in prefrontal grey matter volume following cognitive
behavioural therapy (CBT) in a group of patients suffering from
the chronic fatigue syndrome (CFS).
Dr Bramsen raises two points of criticism. First, she questions
the lack of a control group of patients receiving no treatment or
a different treatment. While this limitation was already empha-
sized in the discussion section of de Lange et al. (2008), it remains
unclear how the observed behavioral and cerebral changes
could be accounted for by generic and CBT-independent factors.
Dr Bramsen wonders whether the reported behavioural improve-
ments are really the result of CBT, or whether they could be
due to natural course or lifestyle changes, while the underlying
disease process is not influenced by CBT. A large body of evidence
suggests that this is not the case: there is overwhelming evidence
in the literature from several carefully conducted randomized
controlled trials (RCT) that demonstrate the specific efficacy of
CBT for CFS (e.g. Sharpe et al. 1996; Deale et al. 1997; Prins
et al. 2001). It was beyond the scope of this study to disprove
that treatments other than CBT would have resulted in the same—
or even better—results, simply because this possibility has already
been tested and rejected (Whiting et al. 2001; Chambers et al.
2006).
The second point of criticism raised is that the structural
changes in the brain are small, comprising 51% of the total
brain volume. Dr Bramsen argues that, although statistically sig-
nificant, these changes are unlikely to be clinically relevant. This
argument is more an intuition than a scientific argument. Given
the limited knowledge of structural plasticity in the adult human
brain, it seems arbitrary to set an a priori threshold for clinical
relevance. More importantly however, Dr Bramsen neglects the
fact that the reported increase in grey matter volume was
largely regionally specific, confined to left and right lateral pre-
frontal cortex [see Fig. 3 of de Lange et al. (2008)]. The increase
in grey matter volume might appear numerically modest when
expressed in terms of whole-brain grey matter volume. Yet,
when relating the change to a more specific anatomical structure
(the lateral prefrontal cortex), the increase in grey matter volume
was on average 8%. Nevertheless, we prefer to focus on whole-
brain grey matter volume as a dependent measure, as it is a
reliable, sensitive and unbiased measure of overall cerebral
morphology (Good et al. 2001; Chard et al. 2002).
In summary, while our study did not compare the efficacy of
CBT in bringing about the behavioural and brain changes with
other treatments or no treatment, there is an overwhelming
amount of evidence from the literature that shows the specific
efficacy of CBT. The size of the structural changes should naturally
be interpreted in relation to the dependent measure used. Finally,
we agree with Dr Bramsen that our results do open a wide array
of new questions, like: ‘What is the long-term time course of these
structural brain changes?’ and ‘Can successful CBT also lead to
structural brain changes in other psychopathologies, e.g. depres-
sion?’ These exciting research questions will hopefully be the topic
of future studies.
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